Submitted by Armen Hareyan on Aug 15th, 2007
Pentostatin For Injection
Bedford Laboratories announced FDA approval to begin shipping Pentostatin for Injection.
This product is AP rated and is equivalent to Nipent by Hospira Inc. Pentostatin is indicated for the treatment of hairy cell leukemia.
"In our continuing effort to offer the most comprehensive and cost effective line of oncology and oncology adjunct products in the multisource industry, Bedford Laboratories is once again very pleased to offer this very important product," said David Gaugh, Vice President of Bedford Laboratories.
Bedford Laboratories will supply latex-free Pentostatin for Injection as a sterile lyophilized powder in a single-dose vial containing 10mg of pentostatin. Prescribing information is available upon request from the Bedford Laboratories' professional services department at 800.521.5169, or from the company's web site, www.bedfordlabs.com.
Bedford Laboratories supplies the US and International markets with multisource and specialty injectable products. Headquartered in Bedford, Ohio, Bedford Laboratories is a division of Ben Venue Laboratories, Inc., a subsidiary of Boehringer Ingelheim Corporation located in Ridgefield, CT, and is a part of the Boehringer Ingelheim group of companies.
Source:
Bedford Laboratories 